Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Gottesman

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|May 17, 2013
The role of the NIH in nurturing clinician-scientistsMichael M Gottesman
Annual Review of Medicine|January 31, 2002
Mechanisms of cancer drug resistanceMichael M Gottesman
Cancer Gene Therapy|July 2, 2003
Cancer gene therapy: an awkward adolescenceMichael M Gottesman
Assay and Drug Development Technologies|July 17, 2009
An interview with Michael M. Gottesman, M.D. Interview by Vicki GlaserMichael M Gottesman
Molecular Interventions|December 24, 2004
Comparing solid tumors with cell lines: implications for identifying drug resistance genes in cancerGergely Szakács, Michael M Gottesman
Science Translational Medicine|April 17, 2015
Beyond 3D culture models of cancerKandice Tanner, Michael M Gottesman
FEBS Letters|January 13, 2006
The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein researchMichael M Gottesman, Victor Ling
Academic Medicine : Journal of the Association of American Medical Colleges|October 29, 2010
Commentary: A delicate balance: weighing the effects of conflict-of-interest rules on intramural research at the National Institutes of HealthMichael M Gottesman, Holli Beckerman Jaffe
Journal of the National Cancer Institute|August 20, 2015
The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) GeneMichael M Gottesman, Ira H Pastan
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2009
Mechanisms of multidrug resistance in cancerJean-Pierre Gillet, Michael M Gottesman
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|May 17, 2013
The role of the NIH in nurturing clinician-scientistsMichael M Gottesman
Annual Review of Medicine|January 31, 2002
Mechanisms of cancer drug resistanceMichael M Gottesman
Cancer Gene Therapy|July 2, 2003
Cancer gene therapy: an awkward adolescenceMichael M Gottesman
Assay and Drug Development Technologies|July 17, 2009
An interview with Michael M. Gottesman, M.D. Interview by Vicki GlaserMichael M Gottesman
Molecular Interventions|December 24, 2004
Comparing solid tumors with cell lines: implications for identifying drug resistance genes in cancerGergely Szakács, Michael M Gottesman
Science Translational Medicine|April 17, 2015
Beyond 3D culture models of cancerKandice Tanner, Michael M Gottesman
FEBS Letters|January 13, 2006
The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein researchMichael M Gottesman, Victor Ling
Academic Medicine : Journal of the Association of American Medical Colleges|October 29, 2010
Commentary: A delicate balance: weighing the effects of conflict-of-interest rules on intramural research at the National Institutes of HealthMichael M Gottesman, Holli Beckerman Jaffe
Journal of the National Cancer Institute|August 20, 2015
The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) GeneMichael M Gottesman, Ira H Pastan
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2009
Mechanisms of multidrug resistance in cancerJean-Pierre Gillet, Michael M Gottesman
Pageof 22